Glenmark gets USFDA nod

Drug major Glenmark Pharma on Tuesday said it has received final approval from the US health regulator for Clobetasol Propionate Foam, indicated for treatment of plaque psoriasis. The approved product is a generic version of Olux-E Foam, 0.05 per cent, of Mylan Pharmaceuticals. Continue Reading